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Summary
Actin polymerization in cells occurs via filament elon-
gation at the barbed end. Proteins that cap the barbed
end terminate this elongation. Heterodimeric capping
protein (CP) is an abundant and ubiquitous protein
that caps the barbed end. We find that the mouse ho-
molog of the adaptor protein CARMIL (mCARMIL)
binds CP with high affinity and decreases its affinity
for the barbed end. Addition of mCARMIL to cell ex-
tracts increases the rate and extent of Arp2/3 or spec-
trin-actin seed-induced polymerization. In cells, GFP-
mCARMIL concentrates in lamellipodia and increases
the fraction of cells with large lamellipodia. Decreas-
ing mCARMIL levels by siRNA transfection lowers the
F-actin level and slows cell migration through a
mechanism that includes decreased lamellipodia pro-
trusion. This phenotype is reversed by full-length
mCARMIL but not mCARMIL lacking the domain that
binds CP. Thus, mCARMIL is a key regulator of CP
and has profound effects on cell behavior.
Introduction
Actin polymerization, essential for cell migration, oc-
curs primarily through elongation at the filament barbed
end. The time and place of polymerization in a migrat-
ing cell is determined by local de novo nucleation of a
filament with a free barbed end and/or by local severing
or uncapping of an existing filament. Filament elonga-
tion then continues until the barbed end is capped by
a capping protein. Often capping is rapid, thereby ac-
counting for the very short filaments in the branched
network of lamellipodia. Rapid capping gives the cell
temporal and spatial control over where filaments
elongate.
Because the barbed ends of most filaments in the
cell are capped, the cytoplasmic pools of G-actin and*Correspondence: yangc@sas.upenn.edu (C.Y.); szigmond@sas.
upenn.edu (S.H.Z.)
5 Present address: Structural Biochemistry Group, ISMB, University
of Edinburgh, Edinburgh, EH9 3JR, United Kingdom.
4 Present address: Lankenau Institute for Medical Research, 100
Lancaster Avenue, Wynnewood, Pennsylvania 19096.profilin actin are maintained at a high level, rarely
achieving steady state with free barbed ends. This
large pool of monomeric actin allows rapid elongation
by those barbed ends that become free. The in vitro
movement of beads coated with proteins that activate
the Arp2/3 complex depends on these pools of mono-
meric actin and thus requires a CP (Loisel et al., 1999).
Capping protein (CP), the nonmuscle homolog of
capZ, is considered to be one of the key factors limiting
the duration of filament elongation (DiNubile et al.,
1995; Hug et al., 1995; Hopmann et al., 1996; Hopmann
and Miller, 2003; Mejilano et al., 2004). CP is found in
all eukaryotic cells, usually at high concentrations (1–3
M), and it binds barbed ends with high affinity (KD
0.1–1 nM) (Cooper and Schafer, 2000; Wear et al., 2003).
The off-rate of CP is slow (t1/2 w25 min), thus filaments
in the lamellipodia may only rid themselves of CP by
fully depolymerizing from their pointed end. Decreasing
the concentration of CP in cells results in longer actin
filaments in both Dictyostelium and mammalian cells
(Hug et al., 1995; Mejilano et al., 2004). In the cell, not
all filaments are short. Long actin filaments are charac-
teristic of filopodia (Svitkina et al., 2003) and cells de-
pleted of CP produce filopodia rather than lamellipodia
(Mejilano et al., 2004). Thus, factors affecting filament
length could determine the properties on actin-contain-
ing structures.
Regulation of barbed-end capping is emerging as a
key mechanism of actin polymerization. Factors inhibit
capping either by binding to the filament and protecting
it from CP or by binding to CP and inhibiting its capping
activity or by uncapping. Formins nucleate filaments
and then transiently protect the new filament’s barbed
end from capping (Moseley et al., 2003; Zigmond et al.,
2003; Harris et al., 2004). VASP, an F-actin binding pro-
tein, inhibits capping by CP in vitro and increases fila-
ment length in vivo (Bear et al., 2002). Capping by Eps8,
a newly discovered CP, is activated by binding to Abi1
(Disanza et al., 2004). Other F-actin binding proteins
such as tropomyosin and members of the ADF family
including coactosin can, by steric inhibition and/or by
altering the filament structure, interfere with capping
proteins (Rohrig et al., 1995; Nyakern-Meazza et al.,
2002; Li et al., 2004).
Phosphoinositides bind and inhibit both gelsolin and
CP; the proteins V-1/myotrophin and CKIP-1 bind and
specifically inhibit CP (Taoka et al., 1994; Chellaiah
and Hruska, 1996; Schafer et al., 1996; Yang et al.,
1998; Allen, 2003; Taoka et al., 2003; Yin and Janmey,
2003; Canton et al., 2005). Phosphoinositides are the
only molecules known to uncap capped filaments; no
uncapping proteins have been reported thus far. Twin-
filin binds CP but does not affect its capping activity;
rather this binding is necessary for the localization and
activity of twinfilin (Falck et al., 2004). The scaffolding
protein CMS/CD2AP/CIN85 binds CP, but its effect on
capping activity is unknown (Hutchings et al., 2003).
CARMIL, a protein isolated from Dictyostelium, binds
CP as well as myosin type I and the Arp2/3 complex
(Jung et al., 2001). Dictyostelium CARMIL activates
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Gfrom Acanthamoeba, on CP activity are unknown
(Remmert et al., 2003). Dictyostelium amoebae with n
tmutations in CARMIL have defects of cell migration, en-
docytosis, and chemotaxis. The basis for these effects, s
ngiven the multiple binding partners of Dictyostelium
CARMIL, could include regulation of the distribution t
and/or activity of any of these binding partners.
To further explore the interaction between CARMIL l
cand CP, we cloned and expressed fragments of human
and mouse homologs of CARMIL as well as full-length K
imouse CARMIL (mCARMIL). We found that recombi-
nant mammalian CARMIL binds CP with high affinity s
tand inhibits its capping activity. Interestingly, these
CARMILs also rapidly uncap filaments pre-capped by K
RCP, a property not observed with either formins or V-1.
In vivo, GFP-CARMIL localizes to the front of lamelli- w
apodia. Overexpression of CARMIL enhances lamelli-
podia formation, while decreasing CARMIL with siRNA t
(dramatically decreases lamellipodia formation and
slows cell migration. The phenotype of the siRNA can
be rescued with full-length mCARMIL but not with C
mCARMIL lacking the CP binding domain. W
o
GResults
r
eIdentification of Mammalian CARMIL
Mammalian homologs of Dictyostelium CARMIL (Jung C
bet al., 2001) were identified by BLAST searching of EST
databases. Using human and mouse ESTs, we then o
TBLAST searched the genome sequences and identified
a CARMIL homolog on mouse chromosome 13 and hu- f
man chromosome 6. The mouse protein, mCARMIL (ac-
cession number AY437876) predicted from cDNAs has c
p1374 amino acids with a calculated MW of 151.9 kDa
(Figure S1 available with this article online). Northern s
Tblots of human tissue reveal a widely expressed w5.4
kb mRNA that is most abundant in kidney and other b
Cepithelial tissues (Figure 1A).
t
rThe C Terminus of mCARMIL Inhibits
tCP’s Capping Activity
hHis-tagged and GST-fusion proteins of full-length
tmCARMIL and various mCARMIL fragments (Figures
w1B and 1C) were expressed, purified, and tested for ef-
efects on the capping activity of purified recombinant
pCP. Full-length His-tagged mCARMIL increased the rate
tof elongation from seeds in the presence of CP. It did
enot increase polymerization in the absence of seeds,
tindicating that it had no ability to nucleate filaments. A
1GST-fusion protein containing only the C terminus of
mCARMIL, and the comparable fragment of human
CARMIL, also reduced CP’s ability to inhibit barbed- m
Eend elongation (Figure 1B). Expression of truncated
mCARMIL constructs localized the CP inhibition activ- W
vity first to the C-terminal half of the molecule (resides
962–1374) and then to a 123 amino acid fragment (resi- v
adues 962–1084) termed C-1 (red box in Figure 1B).
Other fragments from the C-terminal half, i.e., C-2 and i
FC-3, at concentrations >20 times that at which C-1 in-
hibited capping, showed no inhibition of capping (Fig- i
(ure 1C); at high concentrations (M), C-2 had some
barbed-end capping activity on its own (data not Chown). C-1 constructs before and after cleavage of the
ST tag showed similar levels of CP inhibition (data
ot shown). Dose-response curves of GST-C-1 and His-
agged full-length mCARMIL indicated that they have
imilar activity (Figure 1D). Neither full-length mCARMIL
or C-1 inhibited capping by gelsolin, indicating that
he inhibition was specific for CP (data not shown).
The C-1 region is conserved in all metazoan homo-
ogs thus far examined and contains a number of highly
onserved amino acids (Figure 1E). A basic sequence
XRXKRXK (aa 991–998) is conserved in mammals and
nsects. This region is less conserved in amoeboid ver-
ions of CARMIL. Mutations of R993 to A or E decreased
he ability of C-1 to inhibit CP (Figure 1F). The mutation
991A also inhibited activity but not as severely as
993A (data not shown). Another conserved sequence,
ith 4 basic residues out of 8 (aa 1077–1084), is present
t the C-terminal of C-1. However, a C-1 with the muta-
ion K1077A inhibited capping as well as wild-type C-1
data not shown).
-1 Is a High-Affinity Inhibitor of CP
e determined the Ki of this C-terminal fragment (C-1)
n CP by measuring the concentration dependence of
ST-C-1 on capping activity (Figure 2A). The dose-
esponse curve (using the affinity of CP for the barbed
nds as 1 nM, see Figure 2B) defined the Ki of C-1 for
P as w1.5 nM (range 0.9 to 1.7). Interestingly the inhi-
ition of CP by C-1 was not complete; rather the extent
f inhibition plateaued at 80%–85% (range 70%–95%).
hus the GST-C1/CP complex may retain some affinity
or the barbed end of the actin filament.
To determine if the CP/C-1 complex retained some
apping activity, we examined the concentration de-
endence of capping by CP with and without a con-
tant high concentration (200 nM) of C-1 (Figure 2B).
he data without C-1 gave an affinity of CP for the
arbed end of 1 nM (range 0.3 to 1.5 nM). The data with
-1 could be fit by an equilibrium model assuming that
he CP/C-1 complex had no capping activity, but this
equired the affinity of C-1 for CP to be 10-fold weaker
han that determined above (Figure 2A). On the other
and, the data with C-1 were well fit by the model using
he previously determined KD of C-1 for CP, 1.5 nM, if
e assumed that the CP/C-1 complex caps the barbed
nd with an affinity about 15-fold lower than that of
ure CP. In this experiment, binding of C-1 decreased
he affinity of CP from 1 to 15 nM. Over a series of
xperiments with varying seed numbers and preincuba-
ion times, the CP/C-1 complex capping affinity was
0- to 50-fold weaker than that of CP alone.
CARMIL Rapidly Uncaps Barbed
nds Capped by CP
e next asked whether C-1 could uncap ends pre-
iously capped by CP. CP, once bound, dissociates
ery slowly (koff = 5 × 10−4 s−1; t1/2 w25 min) (Wear et
l., 2003). C-1 was added to a polymerization reaction
n which the filament seeds were pre-capped by CP.
ree barbed ends appeared rapidly, reaching their max-
mal level within 10 s, the shortest time we could assay
Figures 2C and 2D). This result suggests that C-1 binds
P on the barbed end and that this binding results in a
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211Figure 1. Characterization of a Mammalian CARMIL
(A) Northern blot of human CARMIL in different tissues. Northern blotting was performed using a 12-lane MTN blot (Clontech) probed with a
250 bp 5# fragment of the human cDNA. A 5.4 kb mRNA reactive band was revealed.
(B) Diagram of mCARMIL constructs used.
Leucine-rich regions are noted by black squares and regions that inhibit CP by open rectangles. GST- or MBP-fusion proteins expressed in
E. coli were isolated and assayed (at concentrations up to 1 M concentration) for their ability to inhibit capping by CP (8 nM). Fragments
that inhibited capping by more than 50% were scored positive.
(C) The C-1 fragment of mCARMIL inhibits capping by CP. Fragments of mCARMIL were assayed for the ability to increase the rate of
polymerization of 2 M actin nucleated by seeds (0.2 nM) in the presence of CP (4 nM). GST-fusion proteins were tested at 80 nM (GST-C-1,
filled blue circles) or 1 M (GST-C-2, open black square; C-3, filled black squares; N, open pink triangle). Also shown are seeds alone (no CP,
open red circles), seeds with CP and no CARMIL (open green circles), and G-actin alone without seeds (half-filled red squares). Pyrenylactin
fluorescence is plotted versus time in s.
(D) Full-length CARMIL and C-1 have similar abilities to inhibit CP.
Actin (1 M) was nucleated by seeds (0.1 nM) in the presence of CP (4 nM) and various concentrations of full-length His-tagged mCARMIL
(red triangles) and GST-C-1 (green symbols, two different experiments indicated by circles and squares). The initial rate of elongation is
plotted as a percentage of the rate observed with seeds alone (no CP) versus mCARMIL concentration.
(E) Sequence alignment of CARMIL C-1 regions. The amino acid sequences of C-1 from mouse (mCARMIL-AY: 437876), aligned with similar
sequences from the databases of rat (rCARMIL, GI: 34876156), human (hCARMIL, GI: 15147715), mosquito (agCP4344, GI: 31210773), Dro-
sophila (CG1399PB, GI: 22024065), and Dictyostelium (dCARMIL, GI: 14701866). Totally conserved residues (*); very conserved changes (two
dots); conserved residues (one dot); and K991 and R993 (!) are noted. The comparable sequence for Acanthamoeba (Acn125) is shown
separately because it diverges significantly in this region.
(F) R993 contributes to inhibition of capping activity. Seeds (0.1 nM) alone (filled black diamond) or with CP (3 nM) were incubated with
varying concentrations of wt C-1 (blue squares), R993E-C-1 (red circles), or R993A-C-1 (green triangles) before addition of pyrenylactin and
determination of the rate of polymerization. The data plotted are the initial rate of elongation, as a percentage of the rate observed with seeds
and no CP, versus GST-C-1 concentration.
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(A) Dose response of GST-C-1 on inhibition of capping by several moderate concentrations of CP. Stabilized seeds (0.1 nM) were incubated
with CP at 0.6 nM (squares), 2.2 nM (circles), or 3.8 nM (triangles) and with different concentrations of C-1 for 7 min before adding pyrenylactin
(1 M) and measuring the rate of elongation. The rate of elongation from seeds with 100 nM C-1 and no CP was set as 100%. See Figure 2B
for description of smooth lines fitting curves
(B) Dose response of CP in a high concentration of mCARMIL. Stabilized seeds (0.1 nM) were incubated with different concentrations of CP
or CP plus 200 nM C-1 for 7 min before addition of pyrenylactin and the rate of elongation determined. The elongation rate from seeds in the
presence of 200 nM C-1 was set as 100%.
The smooth lines in (A) and (B) are drawn using consensus best fit equilibrium constants for this and several similar experiments using the
same preparations.
Capping of ends by CP, KD = 1 nM.
Binding of CP to C-1, KD = 1.5 nM.
Capping of ends by CP/C-1 complex, KD = 15 nM. Thus the CP/C-1 complex retains capping activity but with an affinity 10-fold lower (range
in different experiments: 10- to 50-fold) than that of free CP.
(C) GST-C1 rapidly uncaps barbed ends capped with CP. Polymerization of pyrenylactin (1.2 M) nucleated by seeds in the absence or
presence of 2 nM CP. After 600 s, PIP2 (35 M), GST-C1 (200 nM), or GST-C1 and 28 nM Cytochalasin-D (CD) were added (arrow).
(D) Uncapping by 200 nM C-1 is maximal within w15 s. Stabilized seeds (0.6 nM) were incubated without (red dot) or with CP (4 nM) (blue
squares) for 20 min before addition of C-1 (100 nM) for various times before dilution into pyrenylactin and determination of the initial rate of
elongation. The earliest rate measurable after addition of C-1 was w15 s. The rate of elongation of a sample with C-1 present during the
entire 20 min incubation with CP is also shown (green diamond).large (R100-fold) increase in CP’s off-rate (t1/2 from a
n1400 s to <10 s). CARMIL thus differs from two other
inhibitors of CP, formin and V-1, that are not able to t
uncap capped filaments (Taoka et al., 2003) (M.H. and
S.Z., unpublished data). o
t
tC-1 Binds CP Directly and with High Affinity
To investigate how C-1 inhibits CP, we examined the abil- d
gity of glutathione beads coated with GST-C-1 to pull down
pure CP. CP pelleted with beads coated with GST-C-1 but K
enot a GST-N-terminal fragment of mCARMIL or GSTlone (Figure 3A). The C-1 mutant R993E, which does
ot inhibit capping, did not pull down CP. Thus, inhibi-
ion by C-1 involves direct binding to CP.
We next asked if C-1 bound to the C-terminal regions
f CP subunits (approximately the last 30 amino acids)
hat are primarily responsible for its actin-capping ac-
ivity (Wear et al., 2003; Kim et al., 2004). A double-
eletion mutant missing both of these C-terminal re-
ions (CP/) does not bind actin (Wear et al., 2003;
im et al., 2004). However, GST-C1 on beads was
qually able to pull down wild-type (wt) CP and CP/
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213Figure 3. C-1 Binds Directly to CP
(A) Pure CP is pelleted by GST-C-1; binding
to CP is decreased by the R993E mutation.
GST or mCARMIL fusion proteins, GST-N-
mCARMIL, GST-C-1, or GST-R993E-C-1 (each
w500 nM) were incubated with glutathione-
sepharose beads, washed, and then incu-
bated with CP, a heterodimer of α1 and β2 (100
nM). After washing, the bound protein was
eluted with SDS buffer, separated on 10%
SDS-PAGE, and stained with silver.
(B and C) GST-C-1 binds to wt CP and the
CP/ mutant with similar affinity. The ability
of glutathione-sepharose-coupled GST-C-1
to pull down pure CP was determined by
loss of CP from the supernatant. The CP
concentration was constant at 1 M, and
increasing amounts of beads, providing a to-
tal concentration of GST-C1 up to 5 M,
were added. (B) shows representative Tris-
SDS-polyacrylamide gels (12% acrylamide)
illustrating the GST-C1 concentration-depen-
dent depletion of CP or CP/ from the su-
pernatant (S/N). Controls for GST-C-1, wt CP
added, and wt CP pelleted with uncoupled
beads are shown in lanes labeled a–c, and for
CP/ in lanes labeled d–f. (C) is a plot of the
concentration of bound CP (open circles) or
CP/ (filled triangles) versus the concentra-
tion of immobilized GST-C-1. Values are the
mean ± SEM, n = 3. The data were least
squares fit to equation 1. The difference is not
statistically significant (p > 0.7).
(D) CP/ mutant competes with wt CP for
GST-C-1. Actin polymerization was followed
from pyrenylactin fluorescence (a.u.) as a
function of time (s) after nucleation by seeds
in the presence of wt CP (3 nM) in the ab-
sence or presence of GST-C-1 (250 or 125
nM), and in the absence or presence of vari-
ous concentrations of CP/. CP/ at high
concentrations completely relieved the GST-
C-1-mediated inhibition of CP’s capping ac-
tivity. Actin was used at 2 M (5.8% pyrene
labeled).(Figures 3B and 3C). Thus, C-1 does not bind to these
C-terminal regions of CP. We confirmed this result with
a functional assay. We added the CP/ to a seeded
actin assembly assay containing wt CP (at 3 nM) and
a nearly saturating concentration of GST-C-1, 125 nM
(Figure 3D). Increasing amounts of CP/ relieved the
GST-C-1-mediated inhibition of wt CP’s capping ac-
tivity (green time courses, Figure 3D), indicating that
CP/ successfully competed with wt CP for binding to
GST-C-1.
mCARMIL Binds CP and Enhances Actin
Polymerization in a Cell Extract
Although pure mCARMIL and CP interact, it is impor-
tant to determine if this interaction also occurs in cyto-
plasm. First, we found that GST-C-mCARMIL-coated
beads could pull down CP from high-speed superna-tant of lysed neutrophils (Figure 4A). Thus, C-1 can bind
CP in cytoplasm. Second, immunoprecipitation of en-
dogenous CP from HeLa cell extract pulled down en-
dogenous CARMIL (Figure 4B). Thus, the CARMIL-CP
complex exists in cytoplasmic extracts. We were un-
able to perform the converse reaction since none of our
CARMIL antibodies work for immunoprecipitation.
To examine the functional activity of mCARMIL in cell
extracts, we induced actin polymerization from barbed
ends in a neutrophil extract by adding the VCA frag-
ment of N-WASP to activate the Arp2/3 complex (Figure
4C). Addition of full-length mCARMIL had no effect on
its own, indicating that it did not stimulate nucleation
but addition did enhance the rate and extent of poly-
merization induced by VCA. Addition of the C-terminal
half of mCARMIL also increased the rate and extent
of polymerization induced by VCA or by spectrin-actin
seeds (Figure 4C, middle and right panels).
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Figure 4. mCARMIL Binds and Inhibits CP in Cell Extracts c
(A) GST-C-mCARMIL pulls down CP from cell extract. GST (w2 m
mM) or mCARMIL fusion proteins, GST-FL mCARMIL(GST-FL), i
GST-N-mCARMIL (GST-N), or GST-C-mCARMIL (GST-C), were incu-
Ibated with glutathione-sepharose beads, washed, and then incu-
Gbated with high-speed supernatant of lysed neutrophil (HSS). After
swashing, bead bound CP was analyzed by Western blot with anti-
body against CP β chain. t
(B) Endogenous mCARMIL and CP coimmunoprecipitate. High- d
speed extracts of Hela cells were incubated with rabbit anti-CP
antibody (R26) or a control rabbit IgG. The immunoprecipitates
iwere analyzed by Western blots probed with antibody against
fmCARMIL or CP.
t(C) mCARMIL enhances barbed-end actin polymerization induced
in neutrophil extract. GST-VCA (left [20 nM] and middle [10 nM] m
panels), seeds ([10 nM] right panel), or buffer (all panels) was added m
to cell extract containing 1 M pyrenylactin in the absence (open t
black symbols) or presence of full-length mCARMIL (0.9 M, left
(panel) or the C terminus of mCARMIL (0.5 M, middle and right
panels). Symbols: GST-VCA or seeds without mCARMIL (open blue
osymbols); with mCARMIL (filled red circles); mCARMIL without
GST-VCA or seeds (red open circles). GST-VCA without mCARMIL i
(open blue squares). Polymerization was followed by the increase d
in pyrenylactin fluorescence. c
r
mIncreases in F-actin could have resulted from either
tincreased nucleation or decreased capping. Increased
snucleation was a consideration because Dictyostelium
dCARMIL can weakly activate the Arp2/3 complex (Jung
set al., 2001). To discriminate between these alterna-
tives, we determined whether the total number of
barbed ends present changes: they would not increase C
aif mCARMIL merely uncaps but would increase if
mCARMIL stimulated de novo filament nucleation. To H
hdetermine the total number of barbed ends, parallel
samples of supernatant in the presence or absence of t
CC-1 were stimulated with VCA and then diluted 50-fold
into pyrenylactin containing PIP2, which uncaps barbed t
fends (Schafer et al., 1996). The rate of polymerization
after dilution is thus proportional to the total number of oarbed ends. C-1 had no effect on the total number of
ilaments alone or in the presence of VCA (Figure S2).
n the other hand, when the samples were diluted into
yrenylactin without PIP2 (where, because the off-rate
f pure CP is slow, the rate of polymerization is propor-
ional to the number of free barbed ends), C-1 did in-
rease the rate of polymerization (Figure S2). Thus, the
timulation of polymerization by C-1 is due to de-
reased capping not increased nucleation.
Inhibition of CP should slow the rate of capping and
hereby increase the lengths of the actin filaments in
he extract. We found this to be the case. Addition of
-1 increased the median length of actin filaments in-
uced by VCA, measured by fluorescent phalloidin
taining (Figure S3). Together these results show that
-1 enhances polymerization in cytoplasm by inhibiting
apping, as it does with pure proteins.
ocalization of GFP-mCARMIL in Human
lioblastoma Cells
FP-tagged full-length mCARMIL (FL mC) expressed in
lioblastoma cells was highly concentrated in lamelli-
odia. When expressed in cells expressing YFP-tagged
P, the two colocalized (Figure 5A). GFP-mCARMIL co-
ocalized with F-actin in lamellipodia but did not con-
entrate with F-actin in stress fibers (Figure 5B). When
ells were lysed before fixation, the GFP-mCARMIL re-
ained concentrated in the lamellipodia and colocal-
zed with a lamellipodial marker cortactin (Figure 5C).
n contrast, cytoplasmic label was lost upon lysis when
FP alone was transfected. This supports the conclu-
ion that mCARMIL enrichment in lamellipodia is due
o its specific association with the cytoskeleton but not
ue to a local variation in cell volume.
To determine the region of mCARMIL responsible for
ts localization, we expressed GFP fused to different
ragments of the protein. The distribution of a GFP-
agged fragment containing both the middle and C-ter-
inal of mCARMIL (MC) was similar to that of full-length
CARMIL; however, neither the C terminus alone, the N
erminus alone, nor GFP itself localized to lamellipodia
Figures 5B and 5C; see also Figure 7A).
We also noted in these experiments that expression
f full-length mCARMIL altered cell morphology by
ncreasing the fraction of cells with large lamellipo-
ia (Figures 5A and 7B). While 11% (11/104) of control
ells had lamellipodia covering >10% of the cell pe-
imeter, 80% (86/108) of the cells expressing GFP-
CARMIL had such lamellipodia. These data suggest
hat mCARMIL positively regulates lamellipodial protru-
ion. To further investigate this idea, we inhibited en-
ogenous CARMIL in human glioblastoma cells using
iRNA.
ARMIL siRNA Decreased Cell Migration
nd Lamellipodial Protrusion
uman glioblastoma cells were treated with siRNA for
uman CARMIL (CARMIL siRNA). The efficiency of
ransfection was w90%, and the total concentration of
ARMIL was decreased by greater than 50% relative
o cells treated with siRNA for CARMIL (control siRNA)
rom a different species (mouse) (Figure 6A). Expression
f CARMIL siRNA caused a decrease in the total F-actin
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(A) CARMIL colocalizes with CP in lamellipodia. Cells stably expressing YFP-CP (β2 subunit) were cotransfected with CFP-mCARMIL. Cells
were examined for each fluorophore by confocal microscopy. Shown are CFP-CARMIL (green), YFP-CP (red), and the merged image.
(B) Middle domain of mCARMIL mediates lamellipodia localization.
Glioblastoma cells were transfected with GFP-vector (vector), GFP full-length mCARMIL (FLwt), GFP-N terminus (N), GFP-middle to C terminus
(MC), GFP-C-terminus, (C). Cells were fixed and stained with rhodamine phalloidin before viewing in the confocal microscope.
(C) Full-length and middle domain of mCARMIL colocalize with cortactin in lysed cells. Glioblastoma cells were cotransfected with pDsRed2-
cortactin and GFP-vector (vector), or GFP-full length mCARMIL or GFP-tagged mCARMIL fragments. The cells were extracted with 1% Triton
X-100 in PEM buffer (100 mM PIPES, [pH 6.9], 1 mM MgCl2, 1 mM EGTA) containing 4% PEG, MW 35,000, for 5 min followed by fixation with
4% paraformaldehyde before viewing in the confocal microscope.per cell (Figure 6A). This is consistent with an increase
in CP activity lowering the fraction of free barbed ends
and therefore the total F-actin level. Overall cell mor-
phology and actin organization also changed dramati-
cally in CARMIL siRNA-expressing cells. Cells looked
partially retracted and had few lamellipodia (see below).Prominent stress fibers also disappeared, leaving only
occasional short actin bundles scattered in the cyto-
plasm.
Depletion of CARMIL with siRNA decreased various
measures of motility in glioblastoma cells. Cell spread-
ing was slowed: after 3 hr, only 35% ± 5% (n = 264)
Developmental Cell
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(A) Depleting CARMIL decreases F-actin levels. Human glioblastoma cells transfected with siRNA for human CARMIL or control siRNA were
cultured for 5 days. Cells were then lysed and examined for CARMIL content via a Western blot using Arp3 as a loading control (left panel).
Other cells were fixed, permeabilized, stained with TRITC-phalloidin, and photographed using wide-field epifluorescence. The phalloidin
staining (F-actin/cell) was quantified from the photos using ImageJ software. Data are expressed (right panel) as mean ± SEM (N for CARMIL
siRNA = 79, for control siRNA = 105). Student’s t test showed the difference was significant, p < 0.001.
(B) Expression of CARMIL siRNA slowed cell migration in a wound-healing assay. A wound was scratched in confluent cultures of human
glioblastoma cells transfected 4 days earlier with CARMIL siRNA or control siRNA. Shown are representative sections of the wound from
CARMIL siRNA and control siRNA photographed 6 min and 22 hr after wounding.
(C–E) CARMIL siRNA slowed individual cell migration. Time lapse movies were acquired at 5 min intervals for 6 hr with 4× objective. (C)
Inhibition of cell speed. Instantaneous cell speed was calculated from time lapse sequences using MetaMorph imaging software. Data are
expressed as mean ± SEM, n = 34 (control siRNA) or 35 (CARMIL siRNA), p < 0.0001. (D and E) Inhibition of directional persistence. (D)
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217had lamellipodia, the GFP C-1mCARMIL was local- ments capped with CP.
Display of representative paths of cells selected on the basis of their rate being near median for the population. (E) Quantification of directional
persistence. The ratio of total distance moved/net displacement was determined for each cell; this value is inversely related to the persistence
in direction of movement. The percentage of cells within a range of values is shown in a histogram (higher value = the less persistence). The
insert shows mean value of this ratio ± SEM, n = 34 (control siRNA) or 35 (CARMIL siRNA); p < 0.0001.
(F–I) Kymograph analysis. Individual frames and kymographs from time lapse movies of control siRNA and CARMIL siRNA cells recorded
every 3 s for 10 min with a 100× objective. The line in individual frames of movies was drawn perpendicular to the tangent of the cell edge at
the point of furthest protrusion; this line was used to generate kymograph using MetaMorph software.
Box and whisker plots for velocity (G), distance (how far a lamellipodium protrudes during a single protrusion/withdrawal cycle) (H), and
frequency of individual protrusion events (I) from kymograph analysis. Dot shows mean; middle line of box shows median; top and bottom of
box indicates 75th and 25th quartile, and whiskers indicate extent of 10th and 90th percentiles, respectively. Data for control siRNA are
derived from 228 events of protrusion in 25 cells, for CARMIL siRNA, from 342 events of protrusion in 32 cells. The differences between
CARMIL siRNA and control siRNA for velocity, protrusion distance, and frequency were each significant at p < 0.0001.of CARMIL siRNA-treated cells were spread (unspread
cells were defined as round cells with not even a small
portion of extended cytoplasm) while 86% ± 1% (n =
194) of control cells (transfected with control siRNA)
were spread. Cell migration in a wound-healing assay
was decreased: control cells completely filled the wound
space within 22 hr, whereas a significant gap remained
between wound edges with CARMIL siRNA cells at the
same time point (Figure 6B). The inhibition of cell migra-
tion was also detected by following individual cell mo-
tility (Figures 6C–6E). Compared to cells treated with
control siRNA, cells treated with CARMIL siRNA moved
50% more slowly (Figure 6C), and the direction of
movement showed less persistence (Figures 6D and 6E).
To determine to what extent the decrease in rate of
cell migration was due to impairment of lamellipodia
protrusion, we monitored lamellipodia movements through
a 100× lens (Figure 6F). CARMIL siRNA caused a dra-
matic inhibition of the protrusive behavior of many
cells. Normal lamellipodia characteristic of control cells
(Figure 6F, top) were rarely formed. Instead, these cells
rapidly extended small, phase dark bleb-like structures
at their margin (Figure 6F, bottom). A fraction of the
CARMIL siRNA cells had a milder phenotype and ex-
tended recognizable lamellipodia (Figure 6F, middle).
However, different parameters of protrusive behavior,
such as the rate, distance, and frequency of protrusion,
were significantly impaired in these residual lamelli-
podia (Figures 6G–6I).
Expression of Full-Length mCARMIL but Not
mCARMIL Lacking the C-1 Domain Rescued
the CARMIL siRNA Phenotype
Morphologically, expression of full-length mCARMIL re-
versed the loss of lamellipodia seen with CARMIL
siRNA. Cells cotransfected with mCARMIL again had
large lamellipodia (Figure 7A). This ruled out the possi-
bility that the effects of CARMIL siRNA were nonspe-
cific. Interestingly, expression of a construct lacking the
C-1 region, C-1mCARMIL, did not restore lamelli-
podia. Rather expression of C-1mCARMIL even in
control cells resulted in a partially retracted morphol-
ogy and reduced lamellipodia and stress fibers (Figure
7A), and in severe cases, they showed blebbing at the
edges. The fraction of cells expressing C-1mCARMIL
that had recognizable lamellipodia was 5-fold smaller
than that of cells expressing GFP alone. Thus, the mor-
phology of cells expressing C-1mCARMIL was similar
to that of cells with CARMIL siRNA. In the few cells thatized at the front of the lamellipodia, consistent with the
localization of mCARMIL being determined by its mid-
dle region and indicating that its localization did not
depend on binding to CP (Figure 7A, 5th column).
To determine whether the migration defects of the
CARMIL siRNA cells depended on the loss of CARMIL’s
ability to bind CP versus some other function mediated
by CARMIL, we examined the ability of full-length
mCARMIL and C-1mCARMIL to rescue. To monitor
rescue quantitatively, we examined the migration of in-
dividual cells. Expression of FL mCARMIL restored the
rate of migration and the directional persistence to
CARMIL siRNA-transfected cells. However, expression
of C-1mCARMIL restored neither the rate of migration
nor the directional persistence (Figures 7B–7D). Indeed,
expression of C-1mCARMIL in control siRNA cells de-
creased the rate of migration and directional persis-
tence to levels similar to those of CARMIL siRNA cells.
Both the movement of cells expressing C-
1mCARMIL and their morphology were similar to those
of CARMIL siRNA cells. Thus, the expression of C-
1mCARMIL had a dominant-negative phenotype. Fur-
thermore, these data indicate that CARMIL function in
both lamellipodial formation and cell migration de-
pends on its ability to bind CP.
Discussion
A growing body of evidence demonstrates that capping
of actin filament barbed ends is critical for actin-depen-
dent mechanisms of cell motility. However, there is little
knowledge regarding local regulation of capping and
targeting of CPs. Capping can be inhibited by proteins
such as formins and VASP that act by protecting fila-
ment barbed ends, while others such as V-1 act by se-
questering CP. Phosphoinositides can uncap actin fila-
ments in vitro, but whether they also uncap in vivo is
difficult to test since the phosphoinositides contribute
to activation of Arp2/3 and thus de novo actin nucle-
ation.
CARMIL from Dictyostelium was shown previously to
bind CP (Jung et al., 2001). However, these studies
have not addressed the functional effects of CARMIL
binding to CP. We report here that mammalian CARMIL
binds CP with high affinity (w1 nM) and significantly
decreases CP’s affinity for barbed ends (by 10- to 100-
fold). Moreover, mCARMIL also rapidly uncaps CP-
capped filaments, increasing the CP off-rate by about
100-fold. This is only protein that is able to uncap fila-
Developmental Cell
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CARMIL, Rescues CARMIL siRNA
(A) Morphology. Cells expressing human
CARMIL si-RNA had a retracted morphology
with few lamellipodia and stress fibers (first
column); coexpression of human CARMIL
siRNA with full-length GFP-tagged mouse
CARMIL resulted in formation of lamellipodia
(second column) that were larger than those
in control cells expressing GFP alone (third
column). Expression of C-1 CARMIL in con-
trol cells resulted in cells that appeared re-
tracted and had few lamellipodia or stress
fibers (fourth column). When small lamelli-
podia were present, the GFP-C-1 mCARMIL
localized at the front with the F-actin (fifth
column, arrows). In each panel cells ex-
pressing the indicated GFP-fusion con-
structs (top row) were stained by phalloidin
(middle row) and photographed by confocal
microscopy. Merged images are shown in a
bottom row.
(B–D) Migration speed and persistence. Time-
lapse movies were acquired as in Figure 6C
for untransfected cells (UT, n = 35), cells trans-
fected with CARMIL siRNA alone (n = 30), with
CARMIL siRNA and full-length mCARMIL (+FL,
n = 39), or with CARMIL siRNA C-1 mCARMIL
(+C-1, n = 34). Other cells were transfected
with control siRNA alone (n = 30), with con-
trol siRNA and full-length mCARMIL (+FL,
n = 34), or with control siRNA and C-1
mCARMIL (+C-1, n = 34).
(B) Display of representative paths of un-
transfected cells, cells transfected with
CARMIL siRNA plus full-length mCARMIL,
and cells transfected with control siRNA plus
C-1 mCARMIL. The traced cells were se-
lected on the basis of their rate being near
median for the population.
(C) Instantaneous speed was calculated as
in Figure 6C. While the reduction in cell
speed caused by mCARMIL siRNA was re-
versed by FL mCARMIL (p < 0.0001), it was
not reversed by C-1-mCARMIL. Rather, ex-
pression of C-1-mCARMIL decreased the
migration rate of cells transfected with con-
trol siRNA cells (p < 0.0001). Cells trans-
fected with control siRNA moved at a rate
similar to that of untransfected cells. Data
are expressed as mean ± SEM.
(D) Inhibition of directional persistence. Quantitation of directional persistence was determined (as in Figure 6E) for the same sets of cells as
described in (A). Expression of C-1 CARMIL did not restore the loss of directional persistence caused by mCARMIL siRNA but rather
resulted in a loss of directional persistence in cells treated with control siRNA (p < 0.001). Control siRNA cells had a directional persistence
similar to that of untransfected cells. Data show the ratio ± SEM, The n values for UT = 34; CARMIL siRNA alone, 30; CARMIL siRNA + FL,
33; CARMIL siRNA + C-1, 34; control siRNA alone, 30; control siRNA + FL, 34; control siRNA + C-1, 32.While binding of Dictyostelium CARMIL to CP was p
Athought to occur at the N terminus, binding of CP by
Acanthamoeba CARMIL (Remmert et al., 2003) and by a
amCARMIL localizes to the C terminus. We narrowed
down the CP binding domain of mCARMIL to a 100 a
tamino acid portion, C-1, that inhibits capping as well
as full-length mCARMIL. Similar activities of full-length f
(CARMIL and C-1 suggest that CARMIL is not an auto-
regulated molecule but could be regulated by addi- r
ttional factors. C-1 contains a stretch of basic residues
highly conserved between mammals and insects. Sub- f
stitutions within this region of a highly conserved
Arg993 and Lys991 decreased binding affinity. The com- tarable region of amoeboid CARMILs retains the key
rg at a position homologous to 993, but surrounding
mino acids are poorly conserved (Figure 2B). For ex-
mple, the Lys991 is converted to Ala in Dictyostelium
nd Pro in Acanthamoeba. Perhaps this substitution con-
ributes to the lower affinity of Acanthamoeba CARMIL
or CP (KD = 400 nM versus 1.5 nM for mCARMIL)
Remmert et al., 2003). This decrease in affinity may not
esult in a different function in vivo since we observed
hat the R993E mutant, which has a decreased affinity
or CP, could still rescue CARMIL siRNA cells.
The region of CP that binds to C-1 does not include
he C-terminal regions required for binding to the
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219barbed end of a filament (Wear et al., 2003). Thus, C-1
does not compete with barbed ends for this critical sur-
face on CP. This eliminates a key potential mode of inhi-
bition. While mCARMIL dramatically decreases the af-
finity of CP for the barbed end, the mCARMIL-CP
complex retains some ability to cap the barbed end.
Energy square analysis (also called microreversibility or
detailed balance; see Supplemental Data) indicates
that C-1’s affinity for CP bound to a barbed end is 10-
to 30-fold lower than for free CP. Thus, C-1 binding to
free CP must include some surface or conformation
that is not available when CP is bound to a barbed end.
This raises the possibility that uncapping is a two-step
process where C-1 binds first in a manner that weakly
inhibits CP and then, when one of the C-terminal re-
gions required for capping releases (each tail has an
off-rate constant of 0.2/s), C-1 acquires access to an
additional binding site that now sterically inhibits re-
binding of the C-terminal region of CP to the barbed
end. The two-step uncapping hypothesis suggests that
C-1 is flexible and able to progressively spread over the
surface of CP. Indeed, circular dichroism analysis of
C-1 indicated that the peptide had little secondary
structure and that no new structural peaks emerged
upon mixing CP with C-1 (Figure S5).
Given the in vivo concentrations of mCARMIL (esti-
mated from Western blots to be between 0.1 and 1 M)
and its affinity for CP (KD w1 nM), much of the
mCARMIL in the cytosol is calculated to be bound to
CP. This is supported by the coimmunoprecipitation of
mCARMIL with CP and from previous experiments
showing that Acanthamoeba CARMIL copurifies with
CP. Furthermore, the two proteins colocalize at the front
of lamellipodia. The localization of CARMIL in lamelli-
podia required a distinct domain localized in the middle
of the CARMIL sequence. Localization did not appear
to depend on binding to CP. Rather, CARMIL may re-
cruit CP to the front of the lamellipodia since CP mislo-
calizes in cells treated with CARMIL siRNA (not shown).
However, because the overall lamellar morphology in
these cells is so disturbed, it is difficult to know if mislo-
calization of CP is directly related to CARMIL depletion.
mCARMIL interacts with CP in cytoplasm, and this
interaction is essential for lamellipodial protrusion and
cell translocation. Dictyostelium CARMIL null mutants
(Jung et al., 2001) have shown decreased migration, al-
though the nature of motility defects remains unclear.
Dictyostelium CARMIL, in addition to binding CP, binds
the SH3 domain of type 1 myosins and binds and acti-
vates nucleation by the Arp2/3 complex. mCARMIL has
regions of amino acid similarity to the major domains
of Dictyostelium CARMIL, but we have detected no ac-
tivation of the Arp2/3 complex by mCARMIL, either with
pure Arp2/3 or in cell lysates. Yet, mCARMIL clearly af-
fects lamellipodial behavior. Overexpression of CARMIL
induced large lamellipodia, while depletion, using either
siRNA or expression of CARMIL lacking the C-1 do-
main, led to a decrease in or complete abrogation of
lamellipodial protrusion. The decrease in lamellipodial
protrusion presumably led to both the decreased rate
of migration and the decreased persistence of translo-
cation. The similar phenotype of siRNA cells and ex-
pression of CARMIL lacking the C-1 domain demon-strate that the ability of CARMIL to bind CP is key to
its cellular function.
The CARMIL-CP complex can still cap barbed ends,
although with a lower affinity than pure CP (w15 nM
versus 1 nM). However, given the concentrations of
both CARMIL and CP in cells, the concentration of the
complex (w0.5 M) should be sufficient to cap barbed
ends. It would be surprising if the ability to uncap a
filament were not utilized by the cell. Indeed, the de-
crease in F-actin observed with siRNA treatment and
the morphology of cells treated with siRNA or C-1
CARMIL are reminiscent of that seen in cytochalasin-
treated cells. This suggests that a loss of CARMIL’s
ability to bind CP results in an increase in capping ac-
tivity. Future studies will be required to determine if ad-
ditional players regulate the ability of CARMIL to func-
tion as an uncapper in vivo.
Experimental Procedures
See Supplemental Experimental Procedures for additional details.
Constructs, Northern, and Recombinant Protein
Blast analysis of the NCBI databases revealed the mouse and hu-
man homologs of Dictyostelium CARMIL. Two overlapping mouse
cDNA clones (BC01229 and UI-M-BH0-aiy-g-05-0-UI) were ob-
tained from the Research Genetics collection at Invitrogen and se-
quenced to give a full-length cDNA sequence (5010 bp) (GenBank
accession number AY437876). Using this cDNA, mouse genomic
database searches indicated that the mCARMIL gene is located on
chromosome 13 and contains 35 introns. The predicted mCARMIL
protein consists of 1374 amino acids with a calculated MW of 151.9
kDa (Figure S1, for full sequence). The human cDNA clone #
COL00695, with homology to C-terminal CARMIL, was a gift from
Dr. Hiroko Hata (University of Tokyo, Japan). The human gene is
located on chromosome 6. The clone for pDsRed-cortactin was the
gift of Dr S. Kojima of Northwestern University.
Northern blots using the human 12-lane MTN blot (Clontech)
were probed with a 250 bp 5# fragment of the human cDNA clone
COL00695 32P-labeled with Randam Primed DNA Labeling Kit (Am-
ersham Pharmacia Biotech); equal loading was determined by hu-
man β-actin.
Recombinant Proteins
DNA fragments for full-length and various fragments of mCARMIL
were amplified by PCR and cloned into pGEX-5X-1 or pMAL-c2X,
and the resulting constructs were fully sequenced to assure that
they were in correct reading frame. Fusion proteins were expressed
in E. coli and isolated via glutathione-sepharose beads or amylose
Resin (BioLabs). Purity of isolated proteins is shown in Figure S4.
His-Tagged mCARMIL Expression in Sf9 Cells
Recombinant baculovirus expressing N-terminal His6-tagged full-
length mCARMIL was constructed using Bac-To-Bac Baculovirus
Expression Systems (Life Tech).
Generation of mCARMIL Antibody
MBP-M-mCARMIL (595–959) was used to immunize rabbits and
antibody was affinity-purified with GST-M-mCARMIL
Preparation of C-1 Mutants
The site-directed mutations replacing Arg993 with glutamic acid or
alanine (R993E and R993A mutants) and Lys991 and Lys1077 with
alanine (K991A and K1077A mutants) were performed using the
QuikChange site-directed mutagenesis kit (Stratagene). The pres-
ence of the desired mutations was confirmed by DNA sequencing.
CP Immunoprecipatation
Protein A beads bound with affinity-purified rabbit antibodies pre-
pared against the unique C-terminal region of the chicken CP β2
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220isoform (R25) or with control IgG were incubated with high-speed p
dsupernatant from HeLa cells overnight at 4°C. Immunocomplexes
were washed and bound proteins were analyzed by Western blots.
C
hCP and CP/ Binding to GST-C-1 Beads
(by Supernatant Depletion
cOne micromole CP or CP/ was incubated with increasing concen-
itrations of GST-C1 bound to glutathione Sepharose-4B beads
p(Pharmacia) for 10 min at 25°C in IP buffer. The beads were pelleted
wand aliquots of supernatant were electrophoresed on SDS gels.
The amount of CP was calculated by densitometry of gels stained
Wwith Coomassie blue using NIH Image software. Bound CP was
splotted versus the total bead-coupled ligand concentration and
(least squares fit to equation 1, using Kaleidagraph v3.6 software
a(Synergy Software, Reading, Pennsylvania).
b
wIsolation of CP and CP Mutant
CP was isolated from E. coli expressing recombinant mouse CP
C(α1β2) (Palmgren et al., 2001). The CP double C-terminal deletion
Cmutant, CP/ (missing the C-terminal 28 amino acids from the α
msubunit and the C-terminal 34 amino acids from the β subunit), was
qpurified from a bacterial expression system with chicken cDNAs as
adescribed (Wear et al., 2003).
i
cActin
a
Actin was isolated from rabbit muscle and gel-filtered and a frac-
j
tion was labeled with pyrene. Actin was stored as calcium ATP-
s
actin but converted to magnesium ATP-actin immediately before
s
use. Assays used between 5% and 30% pyrenylactin; varying the
fraction labeled had no effect on the results.
S
Spectrin-Actin Seeds S
Spectrin-actin seeds (seeds) were isolated from human red blood a
cells and stored in ethylene glycol at −20°C (Casella et al., 1986; w
Zigmond, 1998). The number of barbed ends was determined from
the rate of polymerization monitored by the increase in pyrenylactin A
fluorescence Ex370/Em410) (Cano et al., 1991).
To stabilize seeds for extended incubation in IP buffer, the seeds T
were preincubated in 0.35 M actin and 0.35 M phalloidin in IP G
buffer for 30 min at 25°C. J
t
Uncapping Assays i
The uncapping assay was a modification of the seeded assembly h
assay and performed essentially as described (Schafer et al., 1996).
Uncapping is quantified from the change in the rate of actin poly-
Rmerization, calculated from the slope of the pyrene fluorescence
Rversus time, following addition of either PIP2 or GST-C-1.
A
P
Neutrophil Extract
Extracts of rabbit peritoneal exudate neutrophils were obtained as R
described (Zigmond et al., 1997).
A
Culture and Transfection of Human Glioblastoma Cells l
Human glioblastoma cells (SNB-19 cells) (a gift from Marc Symons,
B
North Shore-Long Island Jewish Research Institute, New York) were
S
transiently transfected with GFP-mCARMIL constructs (cloned into
a
the pEGFP-C2 vector [Clontech]) using lipofectamine 2000 (Invitro-
a
gen).
5
Coexpression of CFP-mCARMIL and YFP-CP was achieved by
Cfirst establishing SNB-19 glioblastoma cells that stably express
apEYFP-CPβ2 by selecting pEYFP-CPβ2 transfected cells using
cG418 at 500 g/ml for 2 weeks and then transfecting these cells
awith pECFP-FL mCARMIL.
t
CsiRNAs
CA specific siRNA for human CARMIL coding region (5#-AAGAAA
dTAGGGAAGGTGGAAC-3#) (hCARMIL siRNA) and a control siRNA
mnucleotide (5#-AAATTTACAGGACTTCAGTCA-3#) from the mouse
cCARMIL coding region were obtained from Dharmacon Research
(Lafayette, Colorado) and Cy3-labeled using a Silencer siRNA la- C
cbeling kit (Ambion). Cells were transfected using Lipofectamine
2000 (Invitrogen). Effects of transfection were analyzed 3 to 5 days bosttransfection. The efficiency of transfection was w90% and the
ecrease in CARMIL, as assayed by Western blots, was R50%.
ell Spreading and Lamellipodia Assays
CARMIL siRNA and control siRNA transfected glioblastoma cells
72 hr posttransfection) were observed with a 20× objective and
lassified as round (bright sphere in phase contrast) or spread (hav-
ng a thin rim or extended cytoplasmic processes). Lamellipodia
resence was evaluated by a “blind” observer on cells co-stained
ith phalloidin.
ounding Assay
iRNA-treated and control siRNA-transfected glioblastoma cells
72 hr posttransfection) were plated in 12-well tissue culture plate
nd grown to near confluency before a line of cells was removed
y scraping with a pipet tip. After washing, fresh culture medium
as added and cells were monitored at various times up to 22 hr.
ell Tracking and Kymography
ells transfected with CARMIL siRNA and control siRNA were
ixed and plated at low density into a 35 mm dish. Timelapse se-
uences of motile cells were acquired 60 hr posttransfection using
n inverted microscope (Eclipse TE2000-U, Nikon) and MetaMorph
maging software (Universal Imaging Corp). During imaging, cell
ultures were maintained at 35°C by heating the microscope stage
nd/or objective lens. Cell paths were generated using Track Ob-
ect tool in MetaMorph. After filming, cells containing CARMIL
iRNA were identified by their Cy3 fluorescence under the micro-
cope.
upplemental Data
upplemental Data include Supplemental Experimental Procedures
nd five figures and can be found with this article online at http://
ww.developmentalcell.com/cgi/content/full/9/2/209/DC1/.
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